Detail akcie Inspire Med Sys Rg online

Business Summary: Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Inspire Medical Systems Inc revenues increased 14% to $912M. Net income increased from $53.5M to $145.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Research and development decrease of 10% to $103.2M (expense). Basic Earnings per Share excluding Extraordinary Items increased from $1.80 to $4.95.